Announcements

 
 
Paul G. Allen Frontiers Group    [to 28 Mar 2020]
https://alleninstitute.org/what-we-do/frontiers-group/news-press/
Press Release
No new digest content identified.
 
 
BMGF – Gates Foundation  [to 28 Mar 2020]
http://www.gatesfoundation.org/Media-Center/Press-Releases
MARCH 25, 2020
Life Sciences Companies Commit Expertise and Assets to the Fight Against COVID-19 Pandemic Alongside Bill & Melinda Gates Foundation
Collaboration to address product development and scale-up challenges posed by the current pandemic

MARCH 24, 2020
Bill & Melinda Gates Foundation Shares Details for Greater Seattle Area Coronavirus Response Grants
Grants include support for vulnerable communities and public information campaign

 
 
Bill & Melinda Gates Medical Research Institute    [to 28 Mar 2020]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.
 
 
CARB-X   [to 28 Mar 2020]
https://carb-x.org/
CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria.
No new digest content identified.
 
 
CEPI – Coalition for Epidemic Preparedness Innovations  [to 28 Mar 2020]
http://cepi.net/
Latest News
UK boosts support for CEPI to spur COVID-19 vaccine development

26 Mar 2020
UK Prime Minister, Boris Johnson, announced today a £210 million (US$270 million) boost in funding for CEPI. The announcement followed a virtual conference with G20 leaders and acknowledged the coalition’s recent global call for $2 billion to progress COVID-19 vaccines through to manufacture.
 
 
Clinton Health Access Initiative, Inc. (CHAI)  [to 28 Mar 2020]
https://clintonhealthaccess.org/
News & Press Releases
No new digest content identified.
 
 
EDCTP    [to 28 Mar 2020]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
Latest news
24 March 2020
Total EDCTP investment in TB research & development rises to € 228 million
On World TB Day 2020, the COVID-19 pandemic is a stark reminder of the global impact and burden of infectious diseases on individual and public health, society and national economies. Since 1997, the World Health Organisation (WHO) has reported on…
 
 
Emory Vaccine Center    [to 28 Mar 2020]
http://www.vaccines.emory.edu/
No new digest content identified.
 
 
European Medicines Agency  [to 28 Mar 2020]
http://www.ema.europa.eu/ema/
News & Press Releases
Press release: EMA advises continued use of medicines for hypertension, heart or kidney disease during COVID-19 pandemic
Last updated: 27/03/2020
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 March 2020
CHMP, Last updated: 27/03/2020
Press release: Global regulators map out data requirements for phase 1 COVID-19 vaccine trials
Last updated: 24/03/2020
Press release: COVID-19: Beware of falsified medicines from unregistered websites
Last updated: 24/03/2020
 
 
European Vaccine Initiative  [to 28 Mar 2020]
http://www.euvaccine.eu/news-events
Latest News
No new digest content identified.
 
 
FDA [to 28 Mar 2020]
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/default.htm
Press Announcements
March 27, 2020 – Coronavirus (COVID-19) Update: Daily Roundup March 27, 2020
 
March 27, 2020 – Coronavirus (COVID-19) Update: FDA takes action to help increase U.S. supply of ventilators and respirators for protection of health care workers, patients
 
March 26, 2020 – Coronavirus (COVID-19) Update: Daily Roundup March 26, 2020
 
March 26, 2020 – FDA Continues to Support Transparency and Collaboration in Drug Approval Process as the Clinical Data Summary Pilot Concludes
March 25, 2020 – Coronavirus (COVID-19) Update: Daily Roundup, March 25, 2020
 
March 24, 2020 – Coronavirus (COVID-19) Update: Daily Roundup, March 24, 2020
 
March 24, 2020 – Coronavirus (COVID-19) Update: FDA takes action to increase U.S. supplies through instructions for PPE and device manufacturers
 
March 24, 2020 – Coronavirus (COVID-19) Update: FDA Helps Facilitate Veterinary Telemedicine During Pandemic
 
March 22, 2020 – Coronavirus (COVID-19) Update: FDA provides update on patient access to certain REMS drugs during COVID-19 public health emergency
 
March 22, 2020 – Coronavirus (COVID-19) Update: FDA Continues to Facilitate Access to Crucial Medical Products, Including Ventilators
 
 
Fondation Merieux  [to 28 Mar 2020]
http://www.fondation-merieux.org/
News, Events
No new digest content identified.
 
 
Gavi [to 28 Mar 2020]
https://www.gavi.org/
Top Stories
26 March 2020
Gavi applauds G20 Leaders’ commitment to supporting the global effort against COVID-19
26 March 2020
What is herd immunity?
26 March 2020
How do we stop the spread of a pandemic in a slum?
 
 
GHIT Fund   [to 28 Mar 2020]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that No new digest content identified.
 
 
Global Fund  [to 28 Mar 2020]
https://www.theglobalfund.org/en/news/
News & Stories
Voices
Re-thinking Global Health Security
27 March 2020
 
 
Sourcing & Management of Health Products
COVID-19 Impact on Supply Chain Logistics: Assessment and Recommendations
27 March 2020

News
Japan Secures $476 million Contribution to the Global Fund
27 March 2020

Funding Model
First Funding Requests Submitted in the 2020-2022 Funding Cycle
26 March 2020

Voices
When Finance Fails: Why Economists Didn’t See a Coronavirus Collapse Coming
25 March 2020

Voices
Fighting Tuberculosis: Lessons for COVID-19
23 March 2020

Updates
Global Fund Supports Countries in Response to COVID-19
23 March 2020
 
 
Hilleman Laboratories   [to 28 Mar 2020]
http://www.hillemanlabs.org/
No new digest content identified.
 
 
Human Vaccines Project   [to 28 Mar 2020]
http://www.humanvaccinesproject.org/media/press-releases/
Press Releases
No new digest content identified.
 
 
IAVI  [to 28 Mar 2020]
https://www.iavi.org/newsroom
Press Releases
No new digest content identified.
 
 
International Coalition of Medicines Regulatory Authorities [ICMRA]
http://www.icmra.info/drupal/en/news
Selected Statements, Press Releases, Research
Global regulatory workshop on COVID-19 vaccine development (March 2020)
Global regulators have published a report today presenting the outcomes of a workshop on COVID-19 vaccine development that was convened under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA).
The meeting report provides an overview of regulatory considerations related to COVID-19 vaccine development and data required for regulatory decision-making on two key points:
:: Pre-clinical data required to support proceeding to first-in-human clinical trials with investigational medicinal products; and
:: The need to address the known theoretical risk that vaccines against COVID-19 enhance the disease prior to starting first-in-human clinical trials.
All participants in the meeting acknowledged the urgency of conducting first-in-human clinical trials with COVID-19 vaccine candidates. The conclusions set out how regulatory authorities around the globe intend to strike the balance between rapid development of vaccines and the need to generate enough robust data to enable decision-making.
The meeting also aimed to encourage exchange of information about the global efforts towards developing new vaccines against COVID-19 through an open dialogue between medicines regulatory authorities around the globe.
About the workshop
The regulatory workshop was held virtually in the context of the ongoing COVID-19 pandemic. It brought together delegates from 17 different countries, representing more than 20 medicines regulatory authorities globally, as well as experts from the World Health Organization and the European Commission, to share their views on the development of vaccines against COVID-19. The meeting was co-chaired by EMA and the US Food and Drug Administration (FDA).
 
 
International Generic and Biosimilar Medicines Association [IGBA]
https://www.igbamedicines.org/
News
COVID-19 / Urgent call to governments – Air freight must reopen for critical medicines and supplies for their manufacture (March 2020)
The International Generic and Biosimilar medicines Association (IGBA), which represents global manufacturers of generic and biosimilar medicines, today requested urgent action by governments and pharmaceutical supply chain stakeholders to reopen air freight routes and ensure patients around the globe can continue to have access to the medicines they need during the COVID-19 pandemic.

COVID-19: Critical to keep the supply chain of essential medicines manufacturing operating at full capacity (March 2020)
IGBA, the International Generic and Biosimilar medicines Association (IGBA), representing global manufacturers of generic and biosimilar medicines, today calls upon the global policy leaders and governments to do everything in their power to keep the manufacturing operations and the supply chain of essential medicines operating at full capacity. This will allow our companies to continue to produce much needed critical medicines. While we support the need to protect healthcare workers and to provide hospitals with essential materials, putting unreasonable restrictions on exports of essential medical supplies or medicines will do more harm than good at this time of urgent need.
 
 
IFFIm
http://www.iffim.org/
Press Releases
Jessica Pulay joins IFFIm Board of Directors
19 Mar 2020
Finance executive brings deep experience of public and private sector funding London, 19 March 2020 – Jessica Pulay has been appointed to the Board of Directors of IFFIm, the International Finance Facility for Immunisation, and will serve a three-year term effective 1 April 2020.

 
IFRC   [to 28 Mar 2020]
http://media.ifrc.org/ifrc/news/press-releases/
Selected Press Releases, Announcements
Global
International Red Cross and Red Crescent Movement appeals for 800 million Swiss francs to assist world’s most vulnerable people in fight against COVID-19
Geneva, 26 March 2020 –-The International Red Cross and Red Crescent Movement on Thursday launched a revised emergency appeal for 800 million Swiss francs (823 million US dollars) to help the world’s most vulnerable communities halt the spread of COVID …
 
 
IVAC  [to 28 Mar 2020]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
Updates
No new digest content identified.
 
 
IVI   [to 28 Mar 2020]
http://www.ivi.int/
Selected IVI News & Announcements
No new digest content identified.
 
 
JEE Alliance  [to 28 Mar 2020]
https://www.jeealliance.org/
Selected News and Events
No new digest content identified.
 
 
MSF/Médecins Sans Frontières  [to 28 Mar 2020]
http://www.msf.org/
Latest [Selected Announcements]
Coronavirus disease COVID-19
MSF calls for no patents or profiteering on COVID-19 drugs and vaccines
Press Release 27 Mar 2020
Geneva/New York — Médecins Sans Frontières (MSF) has called for no patents or profiteering on drugs, tests, or vaccines used for the COVID-19 pandemic, and for governments to prepare to suspend and override patents and take other measures, such as price controls, to ensure availability, reduce prices and save more lives.
Already, Canada, Chile, Ecuador and Germany have taken steps to make it easier to override patents by issuing ‘compulsory licences’ for COVID-19 medicines, vaccines and other medical tools. Similarly, the government of Israel issued a compulsory licence for patents on a medicine they were investigating for use for COVID-19…

Syria
MSF provides relief items and adapts response for COVID-1…
Project Update 27 Mar 2020

Coronavirus disease COVID-19
Preparation is key to cope with the COVID-19 pandemic in Côte d’Iv…
Project Update 27 Mar 2020

Coronavirus disease COVID-19
US must include asylum seekers in COVID-19 response, ra…
Press Release 27 Mar 2020

Coronavirus disease COVID-19
MSF steps up COVID-19 response with activities in Spain
Project Update 25 Mar 2020

Coronavirus disease COVID-19
MSF “deeply surprised” that Iranian authorities put a stop to our COVID-19 Response
Statement 25 Mar 2020

DRC Ebola outbreaks
How the Ebola response failed the people of DRC
Opinion 24 Mar 2020

Tuberculosis
Between war and fragile health systems, tackling TB in Sudan and Sou…
Voices from the Field 24 Mar 2020

Coronavirus disease COVID-19
COVID-19: Avoiding a ‘second tragedy’ for those with TB
Project Update 23 Mar 2020

Coronavirus disease COVID-19
MSF sends hospital and medical team to treat COVID-19 patients in …
Project Update 22 Mar 2020
 
 
National Vaccine Program Office – U.S. HHS  [to 28 Mar 2020]
https://www.hhs.gov/vaccines/about/index.html
NVAC 2020 Meetings
June 9-10, 2020 NVAC Meeting
September 23-24, 2020 Meeting (Virtual)
 
 
NIH  [to 28 Mar 2020]
http://www.nih.gov/news-events/news-releases
Selected News Releases
The National Library of Medicine expands access to coronavirus literature through PubMed Central
March 25, 2020 — PubMed Central is a digital archive of peer-reviewed biomedical and life sciences literature, with access to nearly 6 million full-text journal articles.

COVID-19 workers get training to protect their own health
March 23, 2020 — Special NIH program has trained workers through multiple national health emergencies.
 
 
PATH  [to 28 Mar 2020]
https://www.path.org/media-center/
Selected Announcements
No new digest content identified.
 
 
Sabin Vaccine Institute  [to 28 Mar 2020]
http://www.sabin.org/updates/pressreleases
Statements and Press Releases
Responding to COVID-19 – A Statement by the Sabin Vaccine Institute
Friday, March 27, 2020
 
 
UNAIDS [to 28 Mar 2020]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
27 March 2020
Strengthening services for violence against women and HIV in Indonesia
 
26 March 2020
Community members are driving the AIDS response in northern Myanmar

25 March 2020
Innovative and people-empowered approaches to end TB deaths
 
Thai hospitals to provide three- to six-month supplies of antiretroviral therapy

24 March 2020
Talking about a revolution
 
The volunteer driver in Wuhan

23 March 2020
Tuberculosis—good progress, but not enough

23 March 2020
Mining, drugs and conflict are stretching the AIDS response in northern Myanmar
 
 
UNICEF  [to 28 Mar 2020]
https://www.unicef.org/media/press-releases
Press release
Despite challenges, UNICEF continues to ship vital supplies to affected countries amid soaring number of COVID-19 cases
27/03/2020

Press release
UNICEF scales up support in 145 countries to keep children learning, as COVID-19 forces majority of schools worldwide to close
25/03/2020

Statement
Statement by UNICEF Executive Director Henrietta Fore on the disruption of immunization and basic health services due to the COVID-19 pandemic
25/03/2020

Press release
Global Partnership for Education announces US $8.8 million in funding to help UNICEF with COVID-19 response
25/03/2020

Press release
A global approach is the only way to fight COVID-19, the UN says as it launches humanitarian response plan
COVID-19 Global Humanitarian Response Plan
25/03/2020

Statement
UN launches global humanitarian response plan to COVID-19 pandemic
Remarks by UNICEF Executive Director Henrietta Fore (check against delivery)
25/03/2020

Statement
Interruption to key water station in the northeast of Syria puts 460,000 people at risk as efforts ramp up to prevent the spread of Coronavirus disease
Statement from UNICEF Representative in Syria, Fran Equiza
23/03/2020

Press release
COVID-19: More than 95 per cent of children are out of school in Latin America and the Caribbean
23/03/2020

 
 
Vaccination Acceptance Research Network (VARN)  [to 28 Mar 2020]
https://vaccineacceptance.org/news.html#header1-2r
Announcements
No new digest content identified.
 
 
 
 
Vaccine Confidence Project  [to 28 Mar 2020]
http://www.vaccineconfidence.org/
Latest News & Archive
No new digest content identified.
 
 
Vaccine Education Center – Children’s Hospital of Philadelphia  [to 28 Mar 2020]
http://www.chop.edu/centers-programs/vaccine-education-center
Coronavirus Updates
Frequently Asked Questions about Coronavirus Disease 2019 (COVID-19)
Last Updated: March 19, 2020
Get some fast facts about the coronavirus from CHOP and the CDC. The CDC will provide updated information as it becomes available.
 
 
Wellcome Trust  [to 28 Mar 2020]
https://wellcome.ac.uk/news
Opinion | 27 March 2020
A new way of developing vaccines for COVID-19 could help the world to prepare for future outbreaks [RNA vaccine development ]
Charlie Weller. Head of Vaccines Programme, Wellcome
 
 
The Wistar Institute   [to 28 Mar 2020]
https://www.wistar.org/news/press-releases
Press Releases
No new digest content identified.
 
 
WFPHA: World Federation of Public Health Associations  [to 28 Mar 2020]
https://www.wfpha.org/
Latest News
No new digest content identified.
 
 
World Organisation for Animal Health (OIE)   [to 28 Mar 2020]
https://www.oie.int/en/for-the-media/press-releases/2020/
Press Releases
No new digest content identified.
 
 
ARM [Alliance for Regenerative Medicine]  [to 28 Mar 2020]
https://alliancerm.org/press-releases/
Press Releases
No new digest content identified.
 
 
BIO    [to 28 Mar 2020]
https://www.bio.org/press-releases
Press Releases
BIO Summit Accelerates Collaboration Between Government & Industry Leaders in Fight Against Covid-19
March 25, 2020
The Biotechnology Innovation Organization (BIO) this week hosted a productive virtual summit intended to foster collaboration among key government agencies and biopharmaceutical innovators with one goal: eradicating Covid-19. The two-day virtual event helped companies working on treatments, diagnostics and vaccines come together to discuss challenges and opportunities with government officials and other stakeholders.

…Company leaders repeatedly expressed the need for speed of action on the part of government agencies to help accelerate the development of new diagnostics, treatments and vaccines. Also, as the discussions over two days unfolded, a number of key areas of concern emerged:

:: The need for innovative and flexible partnerships between industry, government and academia to quickly move the science through the development and regulatory processes;
:: The importance of determining how to best scale up manufacturing capacity when a new diagnostic, therapy or vaccine is available;
:: The urgency in securing funding for agencies and other partners to get resources where they are needed as soon as they are available; and
:: A desire to work with the FDA to establish guidelines for the development of point-of-care diagnostics.

… “Through the collaboration this virtual summit has helped foster,” said Greenwood, “I’m confident we will eradicate this deadly pandemic and be better prepared for the next one.”

To watch the opening plenary session of the virtual summit, click here.

To learn more about how the industry is responding to Covid-19, click here.

To see Jim Greenwood’s comments following the summit, click here.
 
 
DCVMN – Developing Country Vaccine Manufacturers Network  [to 28 Mar 2020]
http://www.dcvmn.org/
News
No new digest content identified.
 
 
IFPMA   [to 28 Mar 2020]
http://www.ifpma.org/resources/news-releases/
Selected Press Releases, Statements, Publications
IFPMA Backgrounder – COVID-19
27 March 2020
[See COVID-19 for detail]
 
 
 
PhRMA    [to 28 Mar 2020]
http://www.phrma.org/
Selected Press Releases, Statements
America’s Biopharmaceutical Companies are Supporting Italy During the Coronavirus Crisis
March 25, 2020
America’s biopharmaceutical companies stand with everyone affected by the coronavirus throughout Italy, and especially the patients and their loved ones, as well as the health care professionals and scientists fighting on the front lines…
Within Italy, biopharmaceutical companies are donating medicine, supplies and other expertise.
Specific company examples include:
:: Bristol-Myers Squibb contributed $1 million to the Red Cross in the Lombardy Region of Italy and donated face masks to local health care facilities.
:: Gilead has initiated two clinical trials in patients who have been infected with COVID-19 to determine the safety and efficacy of remdesivir as a potential treatment for the coronavirus.
:: The Lilly Italia Foundation is donating €1 million of insulin produced by Eli Lilly and Company.
:: Pfizer’s affiliate is donating €2.5 million worth of medicines and vaccines that can be used in the prevention and management of COVID-19 in impacted regions. Pfizer is also dedicating resources to ensure safe and timely home delivery of essential medicines for patients with life threatening and rare diseases, such as hemophilia.
:: Bayer is supporting hospitals in Lombardy, Italy, with a donation of €1 million that is helping procure urgently-needed equipment for intensive care units in hospitals with the greatest needs.
:: Novartis donated €1 million to the National Civil Protection in Campania, Italy.
:: Novo Nordisk offered direct financial support to hospitals most affected by the crisis. The company also set up an internal fundraising whereby the amount collected via the donations of employees will be doubled by the company and donated to the Italian Civil Protection Department. Additionally, Novo Nordisk sponsored an awareness campaign to provide basic information to the Italian elderly population on how they should respond during the coronavirus crisis and how to protect themselves against misinformation and fraud.
:: Sanofi is donating to support the National Civil Protection for the management of this emergency. The company also invited all employees in Italy to donate one hour or more of their work on a voluntary basis. Sanofi also donated €600,000. Additionally, Sanofi is ready to donate 200 thousand hydroxychloroquine-based treatments to the National Healthcare System, for Italian hospitals that will request them to treat patients with complications from COVID-19. In total, the company’s donations equal more than €2 million…

Journal Watch
Vaccines and Global Health: The Week in Review continues its weekly scanning of key peer-reviewed journals to identify and cite articles, commentary and editorials, books reviews and other content supporting our focu-s on vaccine ethics and policy. Journal Watch is not intended to be exhaustive, but indicative of themes and issues the Center is actively tracking. We selectively provide full text of some editorial and comment articles that are specifically relevant to our work. Successful access to some of the links provided may require subscription or other access arrangement unique to the publisher.
If you would like to suggest other journal titles to include in this service, please contact David Curry at: david.r.curry@centerforvaccineethicsandpolicy.org

American Journal of Preventive Medicine
April 2020 Volume 58, Issue 4, p473-612
http://www.ajpmonline.org/current

Research Articles
Pneumococcal Vaccination in Adults Aged ≥65 Years: Cost-Effectiveness and Health Impact in U.S. Populations
Angela R. Wateska, Mary Patricia Nowalk, Chyongchiou J. Lin, Lee H. Harrison, William Schaffner, Richard K. Zimmerman, Kenneth J. Smith
p487–495
Published online: January 27, 2020

American Journal of Public Health
April 2020 110(4)
http://ajph.aphapublications.org/toc/ajph/current

MIGRATION
Influenza Vaccination and Migration at the US Southern Border
Immigration, Immunization/Vaccines, Infections, Health Policy, Other Infections
Alia Sunderji, Katherine Narvaez Mena, Jonathan Winickoff, Judy Melinek and Joshua Sharfstein
110(4), pp. 466–467

American Journal of Public Health
April 2020 110(4)
http://ajph.aphapublications.org/toc/ajph/current

VACCINES
Vaccination Achievements of Cuba Versus the United States Exposed by the 2019 Measles Epidemic
Government, Immunization/Vaccines, Prevention, Public Health Practice, Health Service Delivery
Paul C. Erwin, Nivaldo Linares-Pérez and Vicente Verez-Bencomo
110(4), pp. 467–469

American Journal of Public Health
April 2020 110(4)
http://ajph.aphapublications.org/toc/ajph/current

ETHICS
Public Health Code of Ethics: Deliberative Decision-Making and Reflective Practice
Human Rights, Public Health Practice, Health Policy, Public Health Workers, Ethics, Health Professionals
Lisa M. Lee, Selena E. Ortiz, Greg Pavela and Bruce Jennings

American Journal of Public Health
April 2020 110(4)
http://ajph.aphapublications.org/toc/ajph/current

MEASLES
Measles Outbreak in Minnesota (2017): Roles of an Immunization Information System
Immunization/Vaccines, Infections, Public Health Practice, Public Health Workers, Statistics/Evaluation/Research, Other Statistics/Evaluation/Research
Maureen Leeds, Miriam Halstead Muscoplat, Sydney Kuramoto and Margaret Roddy
110(4), pp. 527–529

American Journal of Public Health
April 2020 110(4)
http://ajph.aphapublications.org/toc/ajph/current

MEASLES
Measles Outbreak in Minnesota (2017): Roles of an Immunization Information System
Immunization/Vaccines, Infections, Public Health Practice, Public Health Workers, Statistics/Evaluation/Research, Other Statistics/Evaluation/Research
Maureen Leeds, Miriam Halstead Muscoplat, Sydney Kuramoto and Margaret Roddy
110(4), pp. 527–529

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 28 Mar 2020)

Measles and mumps outbreaks in Lebanon: trends and links
Lebanon has experienced several measles and mumps outbreaks in the past 20 years. In this article, a case-based surveillance of both measles and mumps outbreaks in Lebanon was carried out in an attempt to outl…
Authors: Talal El Zarif, Mohamed Faisal Kassir, Nazih Bizri, Ghida Kassir, Umayya Musharrafieh and Abdul Rahman Bizri
Citation: BMC Infectious Diseases 2020 20:244
Content type: Research article
Published on: 26 March 2020

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 28 Mar 2020)

What have we learnt from measles outbreaks in 3 English cities? A qualitative exploration of factors influencing vaccination uptake in Romanian and Roma Romanian communities
Since 2016, large scale measles outbreaks have heavily affected countries across Europe. In England, laboratory confirmed measles cases increased almost four-fold between 2017 and 2018, from 259 to 966 cases.
Authors: Sadie Bell, Vanessa Saliba, Mary Ramsay and Sandra Mounier-Jack
Citation: BMC Public Health 2020 20:381
Content type: Research article
Published on: 23 March 2020

Humanitarian Exchange Magazine
Number 77, March 2020
https://odihpn.org/magazine/the-crisis-in-yemen/

Responding to Ebola in the Democratic Republic of Congo
by Humanitarian Practice Network
This edition of Humanitarian Exchange, co-edited with Anne Harmer, focuses on the response to the Ebola outbreak in the Democratic Republic of Congo (DRC). Although at the time of publication the outbreak appeared to have ended, over its course it claimed 2,200 lives, with more than 3,300 infected, making this the world’s second largest outbreak ever.

In the lead article, Natalie Roberts reflects on the extent to which humanitarian actors have applied learning from the outbreak in West Africa in 2014–2016. Richard Kojan and colleagues report on the NGO ALIMA’s flexible, patient-centred approach to reducing mortality, Marcela Ascuntar reflects on lessons learned from community feedback and Bernard Balibuno, Emanuel Mbuna Badjonga and Howard Mollett highlight the crucial role faith-based organisations have played in the response. In their article, Theresa Jones, Noé Kasali and Olivia Tulloch outline the work of the Bethesda counselling centre in Beni, which provides support to grieving families. Reflecting on findings from a recent assessment by Translators without Borders, Ellie Kemp describes the challenges involved in providing clear and accessible information on Ebola and the response, and Sung Joon Park and colleagues explain how humane care and treatment can help increase trust and confidence in the response. Stephen Mugamba and his co-authors highlight the importance of community involvement in Ebola research, and Gillian McKay and her co-authors examine the impact of the Ebola outbreak and response on sexual and reproductive health services.

Stacey Mearns, Kiryn Lanning and Michelle Gayer present an Ebola Readiness Roadmap to support NGOs in preparing for an outbreak, while Edward Kumakech, Maurice Sadlier, Aidan Sinnott and Dan Irvine report on a Gap Analysis tool looking at the communication, community engagement and compliance tracking activities that need to be in place before an Ebola vaccine is deployed. Emanuele Bruni and colleagues describe the development of a new monitoring and evaluation framework for strategic response planning. The edition ends with an article by Adelicia Fairbanks, who argues for an acceptance strategy in the DRC to improve security and access for responding agencies.

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 16, Issue 3, 2020
http://www.tandfonline.com/toc/khvi20/current

Article
RTS,S/AS01 vaccine (Mosquirix™): an overview
Matthew B. Laurens
Pages: 480-489
Published online: 22 Oct 2019

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 16, Issue 3, 2020
http://www.tandfonline.com/toc/khvi20/current

Review
Precision immunization: a new trend in human vaccination
Siyue Jia, Jingxin Li, Yuanbao Liu & Fengcai Zhu
Pages: 513-522
Published online: 29 Jan 2020

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 16, Issue 3, 2020
http://www.tandfonline.com/toc/khvi20/current

Article
Immunogenicity and safety of a dengue vaccine given as a booster in Singapore: a randomized Phase II, placebo-controlled trial evaluating its effects 5–6 years after completion of the primary series
Juliana Park, Sophia Archuleta, May-Lin Helen Oh, Lynette Pei-Chi Shek, Jing Jin, Matthew Bonaparte, Carina Fargo & Alain Bouckenooghe
Pages: 523-529
Published online: 05 Nov 2019

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 16, Issue 3, 2020
http://www.tandfonline.com/toc/khvi20/current

Article
Review of the status and challenges associated with increasing influenza vaccination coverage among pregnant women in China
Suizan Zhou, Carolyn M. Greene, Ying Song, Ran Zhang, Lance E. Rodewald, Luzhao Feng & Alexander J. Millman
Pages: 602-611
Published online: 07 Oct 2019

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 16, Issue 3, 2020
http://www.tandfonline.com/toc/khvi20/current

Article
Infant vaccination against malaria in Mozambique and in Togo: mapping parents’ willingness to get their children vaccinated
Germano Vera Cruz, Amélie Humeau, Lonzozou Kpanake, Paul Clay Sorum & Etienne Mullet
Pages: 539-547
Published online: 18 Oct 2019

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 16, Issue 3, 2020
http://www.tandfonline.com/toc/khvi20/current

Article
Estimating population immunity to poliovirus in Jordan’s high-risk areas
Noha H. Farag, Kathleen Wannemuehler, William Weldon, Ali Arbaji, Adel Belbaisi, Najwa Khuri-Bulos, Derek Ehrhardt, Mohammad Ratib Surour, Nabil Sabri ElhajQasem & Mohammad Mousa Al-Abdallat
Pages: 548-553
Published online: 05 Nov 2019

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 16, Issue 3, 2020
http://www.tandfonline.com/toc/khvi20/current

Review
Computational tools for modern vaccine development
Sunita, Andaleeb Sajid, Yogendra Singh & Pratyoosh Shukla
Pages: 723-735
Published online: 18 Dec 2019

JAMA
March 24/31, 2020, Vol 323, No. 12, Pages 1111-1216
http://jama.jamanetwork.com/issue.aspx

Viewpoint
Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus – Lessons From Previous Epidemics
David L. Swerdlow, MD; Lyn Finelli, DrPH, MS
free access has active quiz has audio
JAMA. 2020;323(12):1129-1130. doi:10.1001/jama.2020.1960
This Viewpoint discusses the concepts of transmissibility and severity as the critical factors that determine the extent of an epidemic, drawing on the previous pandemic of influenza A(H1N1) and epidemics of SARS and MERS to consider what the scope, morbidity, and mortality of the 2019 novel coronavirus (2019-nCoV) epidemic might be.
Audio Interview: COVID-19 Update From China

JAMA
March 24/31, 2020, Vol 323, No. 12, Pages 1111-1216
http://jama.jamanetwork.com/issue.aspx

US Emergency Legal Responses to Novel Coronavirus – Balancing Public Health and Civil Liberties
Lawrence O. Gostin, JD; James G. Hodge Jr, JD, LLM
free access has active quiz has multimedia has audio
JAMA. 2020;323(12):1131-1132. doi:10.1001/jama.2020.2025
This Viewpoint discusses the policy and legal ramifications of the national public health emergency declared by the US government in response the coronavirus disease 2019 (COVID-19) outbreak, and examines the lawfulness of quarantine and other compulsory measures.

JAMA
March 24/31, 2020, Vol 323, No. 12, Pages 1111-1216
http://jama.jamanetwork.com/issue.aspx

Enhancing Private Sector Health System Preparedness for 21st-Century Health Threats – Foundational Principles From a National Academies Initiative
Donald M. Berwick, MD; Kenneth Shine, MD
free access has active quiz
JAMA. 2020;323(12):1133-1134. doi:10.1001/jama.2020.1310
This Viewpoint summarizes recommendations made by National Academies of Sciences, Engineering, and Medicine (NASEM) experts to address the US health system’s preparedness for major threats, highlighting 5 principles to help regions prepare for specific threats as a prelude to partnerships that would facilitate more comprehensive national preparedness.

Journal of Infectious Diseases
Volume 221, Issue 5, 1 March 2020
https://academic.oup.com/jid/issue/221/5

Editor’s Choice
Ebola: Basic and Social Science, Public Health, and Policy at the Crossroads
Giuseppe Ippolito, Francesco Vairo
J Infect Dis, Volume 221, Issue 5, 1 March 2020, Pages 687–689, https://doi.org/10.1093/infdis/jiz108

Journal of Infectious Diseases
Volume 221, Issue 5, 1 March 2020
https://academic.oup.com/jid/issue/221/5

Editor’s Choice
The Costs of Drugs in Infectious Diseases: Branded, Generics, and Why We Should Care
Sydney Costantini, Rochelle P Walensky
J Infect Dis, Volume 221, Issue 5, 1 March 2020, Pages 690–696, https://doi.org/10.1093/infdis/jiz066

Journal of Infectious Diseases
Volume 221, Issue 5, 1 March 2020
https://academic.oup.com/jid/issue/221/5

Long-term Immunogenicity of Measles Vaccine: An Italian Retrospective Cohort Study
Francesco Paolo Bianchi, Pasquale Stefanizzi, Sara De Nitto, Angela Maria Vittoria Larocca, Cinzia Germinario …
J Infect Dis, Volume 221, Issue 5, 1 March 2020, Pages 721–728, https://doi.org/10.1093/infdis/jiz508

Continue reading →

Journal of Pharmaceutical Policy and Practice
https://joppp.biomedcentral.com/
[Accessed 28 Mar 2020]

Public reporting on pharmaceutical industry-led access programs: alignment with the WHO medicine programs evaluation checklist
There has been increased demand for greater public accountability and transparency of private sector-led global health partnership programs. This study critically reviews and pilot tests the World Health Organization (WHO) medicine program checklist as a framework for public reporting and assessing of programs.
Authors: Chukwuemeka A. Umeh, Peter C. Rockers, Richard Laing, Ovi Wagh and Veronika J. Wirtz
Content type: Research
26 March 2020

The Lancet
Mar 28, 2020 Volume 395 Number 10229 p1011-1088, e54-e61
https://www.thelancet.com/journals/lancet/issue/current

Editorial
COVID-19: learning from experience
The Lancet
Over the past 2 weeks, the coronavirus disease 2019 (COVID-19) pandemic has marched relentlessly westward. On March 13, WHO said that Europe was now the centre of the pandemic. A few days later, deaths in Italy surpassed those in China. Iran and Spain had also reported over 1000 deaths as of March 23, and many other European countries and the USA reported increasing numbers of cases, heralding an imminent wave of fatalities. Following the sweep of COVID-19 is a series of dramatic containment measures that reflect the scale of the threat posed by the pandemic. Lockdowns that seemed draconian when instigated in Wuhan only 2 months ago are now becoming commonplace. However, many countries are still not following WHO’s clear recommendations on containment (widespread testing, quarantine of cases, contact tracing, and social distancing) and have instead implemented haphazard measures, with some attempting only to suppress deaths by shielding the elderly and those with certain health conditions.

The initial slow response in countries such as the UK, the USA, and Sweden now looks increasingly poorly judged. As leaders scramble to acquire diagnostic tests, personal protective equipment, and ventilators for overwhelmed hospitals, there is a growing sense of anger. The patchwork of harmful initial reactions from many leaders, from denial and misplaced optimism, to passive acceptance of large-scale deaths, was justified by words such as unprecedented. But this belies the damage wrought by SARS, Middle East respiratory syndrome, Ebola virus, Zika virus, the 2009 H1N1 influenza pandemic, and a widespread acceptance among scientists that a pandemic would one day occur. Hong Kong and South Korea were tested by these previous emerging infections, leaving them better able to scale up testing and contact tracing.
• View related content for this article

Globally, many people are afraid, angry, uncertain, and without confidence in their national leadership. But alongside these dark sentiments, images of solidarity have emerged. Health workers have shown an incredible commitment to their communities and responded with compassion and resolve to tackle the virus despite challenging and sometimes dangerous conditions. Neighbours have organised to support vulnerable people; businesses and national governments have stepped up to provide support for those who need it and strengthen social security and health services. The pandemic has also brought examples of international solidarity, with the sharing of resources, information, and expertise from countries further ahead in the epidemic, or with better results in controlling the spread. China’s experience will be crucial to understanding how to lift restrictions safely.

Inevitably, the next wave of infections will hit Africa and Latin America. The Africa CDC has reported cases in 41 countries; Brazil, Mexico, and Peru have all reported hundreds or thousands of cases. Most African or Latin American countries have only tens or hundreds of ventilators, and many health facilities do not have even basic therapies such as oxygen. Fragile health-care systems would soon be overwhelmed should infection spread widely. People living in poor, overcrowded, urban areas are especially vulnerable; many do not have basic sanitation, could not self-isolate, and have no paid sick leave or social security. In response to the threat, WHO has launched the COVID-19 Solidarity Response Fund, which has raised more than US$70 million, and some regional organisations have taken strong proactive action, sharing information and receiving donations of testing kits and medical supplies. Many national governments have responded swiftly, but many are yet to take the threat of COVID-19 seriously—eg, ignoring WHO’s recommendation on avoiding mass gatherings. Brazil’s President Jair Bolsonaro has been strongly criticised by health experts and faces an intensifying public backlash for what is seen as his weak response.

Alongside the deep distress felt as many countries experience a peak in cases or brace for it, there is also a growing understanding about the importance of the collective and community. Europe and the USA have shown that putting off preparation, in either the hope of containment elsewhere or a mood of fatality, is not effective. It is imperative that the global community takes advantage of this spirit of cooperation to avoid repeating this error in more vulnerable countries. WHO has provided consistent, clear, and evidence-based recommendations; communicated effectively; and navigated difficult political situations shrewdly. The world is not lacking effective global leadership. The central role played by WHO in coordinating the global response must continue, and countries and donors need to support WHO in these efforts.

The Lancet
Mar 28, 2020 Volume 395 Number 10229 p1011-1088, e54-e61
https://www.thelancet.com/journals/lancet/issue/current

Comment
Offline: COVID-19 and the NHS—“a national scandal”
Richard Horton

The Lancet
Mar 28, 2020 Volume 395 Number 10229 p1011-1088, e54-e61
https://www.thelancet.com/journals/lancet/issue/current

Articles
Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures
Rachael Pung, et al

The Lancet
Mar 28, 2020 Volume 395 Number 10229 p1011-1088, e54-e61
https://www.thelancet.com/journals/lancet/issue/current

Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries
Nirmal Kandel, et al

The Lancet
Mar 28, 2020 Volume 395 Number 10229 p1011-1088, e54-e61
https://www.thelancet.com/journals/lancet/issue/current

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou, et al

The Lancet
Mar 28, 2020 Volume 395 Number 10229 p1011-1088, e54-e61
https://www.thelancet.com/journals/lancet/issue/current

Seminar
Middle East respiratory syndrome
Ziad A Memish, Stanley Perlman, Maria D Van Kerkhove, Alimuddin Zumla

New England Journal of Medicine
March 26, 2020 Vol. 382 No. 13
http://www.nejm.org/toc/nejm/medical-journal

Perspective
Defining the Epidemiology of Covid-19 — Studies Needed
Marc Lipsitch, D.Phil., David L. Swerdlow, M.D., and Lyn Finelli, Dr.P.H.

New England Journal of Medicine
March 26, 2020 Vol. 382 No. 13
http://www.nejm.org/toc/nejm/medical-journal

Original Articles
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
Qun Li, et al

PLoS Neglected Tropical Diseases
http://www.plosntds.org/
(Accessed 28 Mar 2020)

Editorial
Central Latin America: Two decades of challenges in neglected tropical disease control
Peter J. Hotez, Ashish Damania, Maria Elena Bottazzi
| published 26 Mar 2020 PLOS Neglected Tropical Diseases
https://doi.org/10.1371/journal.pntd.0007962

PLoS One
http://www.plosone.org/
[Accessed 28 Mar 2020]

A multi-state model analysis of the time from ethical approval to publication of clinical research studies
Anette Blümle, Tobias Haag, James Balmford, Gerta Rücker, Martin Schumacher, Nadine Binder
Research Article | published 27 Mar 2020 PLOS ONE
https://doi.org/10.1371/journal.pone.0230797
Abstract
Background
Results of medical research should be made publicly available in a timely manner to enable patients and health professionals to make informed decisions about health issues. We aimed to apply a multi-state model to analyze the overall time needed to publish study results, and to examine predictors of the timing of transitions within the research process from study initiation through completion/discontinuation to eventual publication.
Methods
Using a newly developed multi-state model approach, we analysed the effect of different study-related factors on each of the transitions from study approval to eventual publication, using a data set of clinical studies approved by a German research ethics committee between 2000 and 2002.
Results
Of 917 approved studies, 806 were included in our analyses. About half of the clinical studies which began were subsequently published as full articles, and the median time from study approval to publication was 10 years. Differences across model states were apparent; several factors were predictive of the transition from study approval to completion, while funding source and collaboration were predictive of the transition from completion to publication.
Conclusions
The proposed multi-state model approach permits a more comprehensive analysis of time to publication than a simple examination of the transition from approval to publication, and thus the findings represent an advance on previous studies of this aspect of the research process.

PLoS One
http://www.plosone.org/
[Accessed 28 Mar 2020]

Knowledge and remaining gaps on the role of animal and human movements in the poultry production and trade networks in the global spread of avian influenza viruses – A scoping review
Claire Hautefeuille, Gwenaëlle Dauphin, Marisa Peyre
Research Article | published 20 Mar 2020 PLOS ONE
https://doi.org/10.1371/journal.pone.0230567

PNAS – Proceedings of the National Academy of Sciences of the United States of America
http://www.pnas.org/content/early/
[Accessed 28 Mar 2020]

The effects of communicating uncertainty on public trust in facts and numbers
Anne Marthe van der Bles, Sander van der Linden, Alexandra L. J. Freeman, and David J. Spiegelhalter
PNAS first published March 23, 2020. https://doi.org/10.1073/pnas.1913678117
Significance
Does openly communicating uncertainty around facts and numbers necessarily undermine audiences’ trust in the facts, or the communicators? Despite concerns among scientists, experts, and journalists, this has not been studied extensively. In four experiments and one field experiment on the BBC News website, words and numerical ranges were used to communicate uncertainty in news article-like texts. The texts included contested topics such as climate change and immigration statistics. While people’s prior beliefs about topics influenced their trust in the facts, they did not influence how people responded to the uncertainty being communicated. Communicating uncertainty numerically only exerted a minor effect on trust. Knowing this should allow academics and science communicators to be more transparent about the limits of human knowledge.
Abstract
Uncertainty is inherent to our knowledge about the state of the world yet often not communicated alongside scientific facts and numbers. In the “posttruth” era where facts are increasingly contested, a common assumption is that communicating uncertainty will reduce public trust. However, a lack of systematic research makes it difficult to evaluate such claims. We conducted five experiments—including one preregistered replication with a national sample and one field experiment on the BBC News website (total n = 5,780)—to examine whether communicating epistemic uncertainty about facts across different topics (e.g., global warming, immigration), formats (verbal vs. numeric), and magnitudes (high vs. low) influences public trust. Results show that whereas people do perceive greater uncertainty when it is communicated, we observed only a small decrease in trust in numbers and trustworthiness of the source, and mostly for verbal uncertainty communication. These results could help reassure all communicators of facts and science that they can be more open and transparent about the limits of human knowledge.

Science
27 March 2020 Vol 367, Issue 6485
http://www.sciencemag.org/current.dtl

Editorial
COVID-19 needs a Manhattan Project
By Seth Berkley
[See Milestones above for full text]

Science
27 March 2020 Vol 367, Issue 6485
http://www.sciencemag.org/current.dtl

In Depth Infectious Diseases
Race to find COVID-19 treatments accelerates
Kai Kupferschmidt, Jon Cohen
WHO launches megatrial to test repurposed drugs and experimental drug candidates.

Science         
27 March 2020 Vol 367, Issue 6485
http://www.sciencemag.org/current.dtl

Fauci’s straight talk
By Jon Cohen
Science27 Mar 2020 : 1414 Full Access
Science interviews the director of NIAID about the coronavirus pandemic.

Vaccine
Volume 38, Issue 13 Pages 2749-2888 (17 March 2020)
https://www.sciencedirect.com/journal/vaccine/vol/38/issue/12

Research article Abstract only
‘Should I vaccinate my child?’ comparing the displayed stances of vaccine information retrieved from Google, Facebook and YouTube
Lucy E Elkin, Susan R.H. Pullon, Maria H. Stubbe

Vaccine
Volume 38, Issue 13 Pages 2749-2888 (17 March 2020)
https://www.sciencedirect.com/journal/vaccine/vol/38/issue/12

Research article Abstract only
The impact of new universal child influenza programs in Australia: Vaccine coverage, effectiveness and disease epidemiology in hospitalised children in 2018
Christopher C. Blyth, Allen C. Cheng, Nigel W. Crawford, Julia E. Clark, … Kristine K. Macartney

Vaccine
Volume 38, Issue 13 Pages 2749-2888 (17 March 2020)
https://www.sciencedirect.com/journal/vaccine/vol/38/issue/12

Research article Abstract only
Are refugees arriving in Denmark an under-immunised group for measles? A cross-sectional serology study
Anne Mette Fløe Hvass, Marie Norredam, Morten Sodemann, Marianne Kragh Thomsen, Wejse Christian

Vaccine
Volume 38, Issue 13 Pages 2749-2888 (17 March 2020)
https://www.sciencedirect.com/journal/vaccine/vol/38/issue/12

Research article Open access
Field challenges to measles elimination in the Democratic Republic of the Congo
R.M. Coulborn, F. Nackers, C. Bachy, K. Porten, … I. Panunzi

Vaccine
Volume 38, Issue 13 Pages 2749-2888 (17 March 2020)
https://www.sciencedirect.com/journal/vaccine/vol/38/issue/12

Research article Abstract only
Quality and reliability of vaccination documentation in the routine childhood immunization program in Burkina Faso: Results from a cross-sectional survey
Lassané Kaboré, Clément Z. Méda, François Sawadogo, Michèle M. Bengue, … Edouard Betsem

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines
(Accessed 28 Mar 2020)

Open Access Article
Healthcare Workers’ Knowledge, Attitudes, and Practices about Vaccinations: A Cross-Sectional Study in Italy
by Concetta P. Pelullo , Giorgia Della Polla , Francesco Napolitano , Gabriella Di Giuseppe and Italo F. Angelillo
Vaccines 2020, 8(2), 148; https://doi.org/10.3390/vaccines8020148 (registering DOI) – 26 Mar 2020
Abstract
The cross-sectional study assessed the knowledge, attitudes, and practices regarding the recommended vaccinations and factors affecting such outcomes among a sample of healthcare workers (HCWs) in public hospitals in Italy. Only 14.1% knew all the recommended vaccinations for HCWs. Physicians and those who had received information about vaccinations from scientific journals, educational activities, or professional associations were more likely to have this knowledge, while those aged 36–45 were more likely to have less knowledge than those in the age group below 36 years. Only 57.3% agreed that the information received about vaccinations was reliable. Respondents who had children, who worked in pediatric/neonatal wards, who were more knowledgeable, or who did not need further information about vaccinations considered the available information to be reliable. Only 17.7% of respondents always recommended vaccinations to their patients. This behavior was more likely to occur in physicians, in HCWs, in pediatric/neonatal wards, in those who considered the information received about vaccinations reliable, and in those who considered themselves to be at high risk of transmitting an infectious disease to their patients. Health promotion programs and efforts are needed to improve the level of knowledge about vaccinations and immunization coverage among HCWs.

From Google Scholar & other sources: Selected Journal Articles, Newsletters, Dissertations, Theses, Commentary

No new digest content identified.

Media/Policy Watch
This watch section is intended to alert readers to substantive news, analysis and opinion from the general media and selected think tanks and similar organizations on vaccines, immunization, global public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.
We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.

The Atlantic
http://www.theatlantic.com/magazine/
Accessed 28 Mar 2020
[No new, unique, relevant content]

BBC
http://www.bbc.co.uk/
[No new, unique, relevant content]

The Economist
http://www.economist.com/
Accessed 28 Mar 2020
[No new, unique, relevant content]

Financial Times
http://www.ft.com/home/uk
Accessed 28 Mar 2020
[No new, unique, relevant content]

Forbes
http://www.forbes.com/
Editors’ Pick  
WHO Must Push For Lower Speed Limits To Ease Pressure On Virus-Impacted Hospitals, Urge Experts
3/28/2020
Medics and other experts are calling on the World Health Organization (WHO) to recommend that national governments should lower speed limits on their roads as a means of reducing hospital admissions during the coronavirus outbreak.
By Carlton Reid Senior Contributor

Mar 27, 2020
AI Can Help Us Fight Infectious Diseases In A More Effective Way
The COVID-19 pandemic has created a sense of urgency to improve current approaches for prevention and treatment of infectious diseases. Fortunately, currently available AI and data science approaches can help us fight infectious diseases in a more effective way and improve human healthcare.
By Margaretta Colangelo Contributor

Foreign Affairs
http://www.foreignaffairs.com/
Accessed 28 Mar 2020
Health   Mar 28, 2020 Snapshot
Ebola Should Have Immunized the United States to the Coronavirus
What Washington failed to learn from the National Security Council’s Ebola report.
Christopher Kirchhoff

China   Mar 27, 2020 Response
Past Pandemics Exposed China’s Weaknesses
From the bubonic plague at the end of the nineteenth century to HIV/AIDS in the 1990s to SARS in 2002–3, China’s ability to contain diseases has been crucial to…
Robert Peckham

China   Mar 24, 2020 Snapshot
The U.S. and China Could Cooperate to Defeat the Pandemic
U.S.-Chinese antagonism could make the coronavirus pandemic worse.
Yanzhong Huang

Foreign Policy
http://foreignpolicy.com/
Accessed 28 Mar 2020 Accessed 28 Mar 2020
Amid Coronavirus Spread, Host Countries Ignore Refugee Health at Their Own Peril
Refugees are particularly vulnerable to a pandemic—which is why their needs must be taken into account.
Argument | March 27, 2020,
Sanjana Ravi

The Guardian
http://www.guardiannews.com/
Accessed 28 Mar 2020
[No new, unique, relevant content]

New Yorker
http://www.newyorker.com/
Accessed 28 Mar 2020
Elements
The Evolution of a Coronavirus
SARS-CoV-2, which honed its viral genome for thousands of years, behaves like a monstrous mutant hybrid of all the coronaviruses that came before it.
March 27, 2020, By Carolyn Kormann

New York Times
http://www.nytimes.com/
Accessed 28 Mar 2020
Europe

UN Health Agency Settles In for Long Fight With Virus
The World Health Organization’s emergencies chief said Friday that widespread testing for the new coronavirus is crucial and countries should not be faulted for reporting higher numbers of cases.
By The Associated Press

Washington Post
https://www.washingtonpost.com/
Accessed 28 Mar 2020
[No new, unique, relevant content]

Think Tanks et al

Brookings
http://www.brookings.edu/
Accessed 28 Mar 2020
Future Development
Awakening in the post-pandemic world
Dennis J. Snower
Friday, March 27, 2020

Order from Chaos
Now is the time to revisit the Global Health Security Agenda
Bonnie Jenkins
Friday, March 27, 2020

Center for Global Development [to 28 Mar 2020]
http://www.cgdev.org/page/press-center
Selected Publications, News and Events
[No new relevant content]

CSIS
https://www.csis.org/
Accessed 28 Mar 2020
[No new relevant content]

Council on Foreign Relations
http://www.cfr.org/
Accessed 28 Mar 2020
[No new relevant content]

Kaiser Family Foundation
https://www.kff.org/search/?post_type=press-release
Accessed 28 Mar 2020
[No new relevant content]